These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 37398677)

  • 21. Peri-operative third party red blood cell transfusion in renal transplantation and the risk of antibody-mediated rejection and graft loss.
    Fidler S; Swaminathan R; Lim W; Ferrari P; Witt C; Christiansen FT; D'Orsogna LJ; Irish AB
    Transpl Immunol; 2013 Dec; 29(1-4):22-7. PubMed ID: 24090807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
    Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presentation and Outcomes of C4d-Negative Antibody-Mediated Rejection After Kidney Transplantation.
    Orandi BJ; Alachkar N; Kraus ES; Naqvi F; Lonze BE; Lees L; Van Arendonk KJ; Wickliffe C; Bagnasco SM; Zachary AA; Segev DL; Montgomery RA
    Am J Transplant; 2016 Jan; 16(1):213-20. PubMed ID: 26317487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C1q binding is not an independent risk factor for kidney allograft loss after an acute antibody-mediated rejection episode: a retrospective cohort study.
    Moktefi A; Parisot J; Desvaux D; Canoui-Poitrine F; Brocheriou I; Peltier J; Audard V; Kofman T; Suberbielle C; Lang P; Rondeau E; Grimbert P; Matignon M
    Transpl Int; 2017 Mar; 30(3):277-287. PubMed ID: 27992962
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
    Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-Mediated Rejection in Lung Transplantation: Clinical Outcomes and Donor-Specific Antibody Characteristics.
    Roux A; Bendib Le Lan I; Holifanjaniaina S; Thomas KA; Hamid AM; Picard C; Grenet D; De Miranda S; Douvry B; Beaumont-Azuar L; Sage E; Devaquet J; Cuquemelle E; Le Guen M; Spreafico R; Suberbielle-Boissel C; Stern M; Parquin F;
    Am J Transplant; 2016 Apr; 16(4):1216-28. PubMed ID: 26845386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept.
    Favi E; Cresseri D; Perego M; Ikehata M; Iesari S; Campise MR; Morello W; Testa S; Sioli V; Mattinzoli D; Longhi E; Del Gobbo A; Castellano G; Ferraresso M
    Clin Immunol; 2024 Jul; 264():110240. PubMed ID: 38734036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
    Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
    Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-transplant soluble CD30 in combination with total DSA but not pre-transplant C1q-DSA predicts antibody-mediated graft loss in presensitized high-risk kidney transplant recipients.
    Schaefer SM; Süsal C; Opelz G; Döhler B; Becker LE; Klein K; Sickmüller S; Waldherr R; Macher-Goeppinger S; Schemmer P; Beimler J; Zeier M; Morath C
    HLA; 2016 Feb; 87(2):89-99. PubMed ID: 26840927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation.
    Cuadrado A; San Segundo D; López-Hoyos M; Crespo J; Fábrega E
    World J Gastroenterol; 2015 Oct; 21(39):11016-26. PubMed ID: 26494958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histologic and Clinical Outcomes of Patients Developing Post-Liver Transplant Plasma Cell-Rich Rejection.
    Ozturk NB; Schiano TD; Fiel MI
    Am J Clin Pathol; 2023 Jul; 160(1):49-57. PubMed ID: 36883807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement blockade with eculizumab to treat acute symptomatic humoral rejection after heart transplantation.
    Yerly P; Rotman S; Regamey J; Aubert V; Aur S; Kirsch M; Hullin R; Pascual M
    Xenotransplantation; 2022 Jan; 29(1):e12726. PubMed ID: 35001433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretransplant replacement of donor liver grafts with recipient Kupffer cells attenuates liver graft rejection in rats.
    Endo K; Hori T; Jobara K; Hata T; Tsuruyama T; Uemoto S
    J Gastroenterol Hepatol; 2015 May; 30(5):944-51. PubMed ID: 25532540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploring pre-surgery donor-specific antibodies in the context of organ shortage in liver transplant.
    Barreto SG; Brooke-Smith ME; Neo EL; Dolan P; Leibbrandt R; Emery T; Carroll R; Wigg A; Chen JW
    Langenbecks Arch Surg; 2019 Nov; 404(7):865-874. PubMed ID: 31748871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
    Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of transplant glomerulopathy early after kidney transplantation.
    Shimizu T; Ishida H; Tanabe T; Shirakawa H; Tanabe K; Honda K; Koike J
    Clin Transplant; 2011 Jul; 25 Suppl 23():34-8. PubMed ID: 21623912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute antibody-mediated rejection in ABO-compatible pediatric liver transplant recipients: case series and review of the literature.
    Wozniak LJ; Naini BV; Hickey MJ; Bhattacharyya S; Reed EF; Busuttil RW; Farmer DG; Vargas JH; Venick RS; McDiarmid SV
    Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27597379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the Correlation Between DSA, Complement Activation, and Antibody-Mediated Rejection in Heart Transplant Recipients.
    Zhang Q; Hickey M; Drogalis-Kim D; Zheng Y; Gjertson D; Cadeiras M; Khuu T; Baas AS; Depasquale EC; Halnon NJ; Perens G; Alejos J; Cruz D; Ali N; Shemin R; Kwon M; Fishbein MC; Ardehali A; Deng M; Reed EF
    Transplantation; 2018 Oct; 102(10):e431-e438. PubMed ID: 29916988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.